TS Financial Group (TSFG)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $117K | Buy |
4,874
+9
| +0.2% | +$235 | 0.01% | 260 |
|
|
2026
Q1 | $137K | Buy |
4,865
+8
| +0.2% | +$213 | 0.02% | 219 |
|
|
2025
Q4 | $121K | Sell |
4,857
-158
| -3% | -$3.98K | 0.02% | 226 |
|
|
2025
Q3 | $128K | Sell |
5,015
-303
| -6% | -$7.48K | 0.02% | 220 |
|
|
2025
Q2 | $129K | Sell |
5,318
-512
| -9% | -$11.9K | 0.02% | 205 |
|
|
2025
Q1 | $148K | Buy |
5,830
+1,752
| +43% | +$45.8K | 0.03% | 175 |
|
|
2024
Q4 | $108K | Sell |
4,078
-685
| -14% | -$18.6K | 0.02% | 202 |
|
|
2024
Q3 | $138K | Sell |
4,763
-22
| -0.5% | -$642 | 0.03% | 181 |
|
|
2024
Q2 | $134K | Sell |
4,785
-127
| -3% | -$3.5K | 0.03% | 170 |
|
|
2024
Q1 | $136K | Sell |
4,912
-1,499
| -23% | -$41.6K | 0.03% | 168 |
|
|
2023
Q4 | $185K | Sell |
6,411
-313
| -5% | -$9.46K | 0.06% | 144 |
|
|
2023
Q3 | $223K | Buy |
6,724
+633
| +10% | +$22.4K | 0.08% | 124 |
|
|
2023
Q2 | $223K | Sell |
6,091
-131
| -2% | -$5.1K | 0.08% | 118 |
|
|
2023
Q1 | $254K | Sell |
6,222
-61
| -1% | -$2.63K | 0.09% | 110 |
|
|
2022
Q4 | $322K | Buy |
6,283
+24
| +0.4% | +$1.15K | 0.13% | 94 |
|
|
2022
Q3 | $274K | Sell |
6,259
-623
| -9% | -$30.3K | 0.13% | 83 |
|
|
2022
Q2 | $361K | Buy |
6,882
+336
| +5% | +$17.1K | 0.16% | 76 |
|
|
2022
Q1 | $339K | Sell |
6,546
-48
| -0.7% | -$2.49K | 0.12% | 82 |
|
|
2021
Q4 | $389K | Buy |
6,594
+1,619
| +33% | +$80.2K | 0.14% | 80 |
|
|
2021
Q3 | $214K | Buy |
4,975
+7
| +0.1% | +$310 | 0.08% | 121 |
|
|
2021
Q2 | $195K | Buy |
4,968
+336
| +7% | +$13.1K | 0.08% | 131 |
|
|
2021
Q1 | $168K | Sell |
4,632
-62
| -1% | -$2.2K | 0.09% | 122 |
|
|
2020
Q4 | $173K | Buy |
4,694
+207
| +5% | +$7.59K | 0.09% | 111 |
|
|
2020
Q3 | $156K | Buy |
4,487
+2,055
| +84% | +$72K | 0.09% | 108 |
|
|
2020
Q2 | $75K | Buy |
2,432
+56
| +2% | +$1.9K | 0.05% | 164 |
|
|
2020
Q1 | $74K | Hold |
2,376
| – | – | 0.07% | 143 |
|
|
2019
Q4 | $88K | Hold |
2,376
| – | – | 0.07% | 156 |
|
|
2019
Q3 | $81K | Hold |
2,376
| – | – | 0.06% | 160 |
|
|
2019
Q2 | $98K | Hold |
2,376
| – | – | 0.08% | 136 |
|
|
2019
Q1 | $96K | Buy |
+2,376
| New | +$95.2K | 0.08% | 135 |
|
Other funds holding PFE
TS Financial Group (TSFG)'s PFE Position: Q2 2026 in Review
TS Financial Group (TSFG) increased its Pfizer (PFE) stake by 0.18% in Q2 2026, buying an estimated $235 and bringing the position to 4,874 shares worth $117K. The position accounts for 0.01% of the portfolio, ranked #260.
TS Financial Group (TSFG) first reported a position in PFE in Q1 2019 and has held it in 30 quarters since. The position peaked at $389K in Q4 2021. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- TS Financial Group (TSFG) held 4,874 shares of Pfizer worth $117K as of Q2 2026.
- TS Financial Group (TSFG) bought 9 Pfizer shares in Q2 2026, an estimated $235.
- Pfizer made up 0.01% of TS Financial Group (TSFG)'s portfolio in Q2 2026, its #260 holding.
- TS Financial Group (TSFG) first reported a position in Pfizer in Q1 2019 and has held it in 30 quarters since.
- TS Financial Group (TSFG)'s Pfizer position peaked at $389K in Q4 2021.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on TS Financial Group (TSFG)'s 13F filing for Q2 2026, filed 23 Jul 2026.